483
Immunodiagnostic Systems SaImmunodiagnostic Systems Sa – FDA 483, Sep 7, 2023
Record Details
An FDA inspection of Immunodiagnostic Systems Sa in Liege, Belgium, revealed significant deficiencies in their corrective and preventive action (CAPA) procedures. The firm's CAPA SOPs did not require effectiveness checks, leading to multiple CAPA reports where effectiveness was either not assessed or only a correction was listed. This indicates a critical breakdown in ensuring the long-term efficacy of corrective actions for product quality issues.
View Company Profile
ID · 887e2449-2349-4398-a5ea-56d8c6998145
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.